Sequential CT screening can identify indolent lung cancers

December 4, 2012
Sequential CT screening can identify indolent lung cancers
Changes in size on sequential low-dose computed tomography screenings, expressed as volume doubling time, indicate that about 25 percent of progressive lung cancers are slow growing or indolent, with higher lung cancer-specific mortality for new versus slow-growing or indolent cancers, according to a study published in the Dec. 4 issue of the Annals of Internal Medicine.

(HealthDay)—Changes in size on sequential low-dose computed tomography (LDCT) screenings, expressed as volume doubling time (VDT), indicate that about 25 percent of progressive lung cancers are slow growing or indolent, with higher lung cancer-specific mortality for new versus slow-growing or indolent cancers, according to a study published in the Dec. 4 issue of the Annals of Internal Medicine.

Giulia Veronesi, M.D., from the European Institute of Oncology in Milan, and colleagues assessed VDT as an indicator of overdiagnosis for screening-detected lung cancer by estimating the VDT in 175 high- who were diagnosed with primary lung cancer. VDT was characterized as fast growing (VDT <400 days), slow growing (VDT between 400 and 599 days), or indolent (VDT ≥600 days).

Within the cohort, 55 cases of cancer were diagnosed at baseline and 120 were diagnosed subsequently. Of the later group, the researchers found that 15.8 percent of tumors were not visible on previous scans and were classified as fast growing (median VDT 52 days); 84.2 percent were progressive (58.3 percent fast growing and 25.8 percent slow growing [15.0 percent] or indolent [10.8 percent]). For patients with new versus slow-growing or indolent cancer, -specific was significantly higher (9.2 versus 0.9 percent per year). Of the incident cancers, 60 percent of fast-growing progressive cancer and 45 percent of new cancers were stage 1.

"Slow-growing or indolent cancer comprised approximately 25 percent of incident cases, many of which may have been overdiagnosed," the authors write. "To limit overtreatment in these cases, minimally invasive limited resection and nonsurgical treatments should be investigated."

Explore further: Asymptomatic often sent for lung cancer screening tests

More information: Full Text (subscription or payment may be required)

Related Stories

Asymptomatic often sent for lung cancer screening tests

March 13, 2012
(HealthDay) -- A majority of primary care physicians report ordering lung cancer screening tests for asymptomatic patients, according to research published in the March/April issue of the Annals of Family Medicine.

New study looks at growth rates of lung cancers found by CT screening

March 27, 2012
Growth rates of lung cancers found by annual rounds of computed tomography (CT) screening are important for determining the usefulness and frequency of screening, as well as for determining the treatment. According to the ...

Video-assisted thoracic surgery valuable tool in lung cancer screening

May 15, 2012
The most recent research released in June's Journal of Thoracic Oncology says video assisted thoracic surgery (VATS) is a valuable tool in managing lesions detected in a lung cancer screening program. The primary objective ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.